000 | 00979 a2200289 4500 | ||
---|---|---|---|
005 | 20250516185027.0 | ||
264 | 0 | _c20150305 | |
008 | 201503s 0 0 eng d | ||
022 | _a1573-7365 | ||
024 | 7 |
_a10.1007/s11011-013-9460-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOkojie, A K | |
245 | 0 | 0 |
_aDepo-provera effects on Wistar rat performance in the Y-maze. _h[electronic resource] |
260 |
_bMetabolic brain disease _cJun 2014 |
||
300 |
_a529-31 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aMaze Learning _xdrug effects |
650 | 0 | 4 |
_aMedroxyprogesterone Acetate _xpharmacology |
650 | 0 | 4 |
_aPsychomotor Performance _xdrug effects |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
700 | 1 | _aOyekunle, O A | |
773 | 0 |
_tMetabolic brain disease _gvol. 29 _gno. 2 _gp. 529-31 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11011-013-9460-9 _zAvailable from publisher's website |
999 |
_c23367076 _d23367076 |